BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 23.42 USD 0.77% Market Closed
Market Cap: 4.4B USD
Have any thoughts about
BridgeBio Pharma Inc?
Write Note

BridgeBio Pharma Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BridgeBio Pharma Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
BridgeBio Pharma Inc
NASDAQ:BBIO
Gross Profit
$215.4m
CAGR 3-Years
58%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$37.3B
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
9%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$22B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.7B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$9.2B
CAGR 3-Years
13%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$12B
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
17%
No Stocks Found

BridgeBio Pharma Inc
Glance View

Market Cap
4.4B USD
Industry
Biotechnology

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. The company is headquartered in Palo Alto, California and currently employs 576 full-time employees. The company went IPO on 2019-06-27. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene therapy. The Company’s pipeline programs include product candidates ranging from early discovery to late-stage development. The Company’s products include BBP-561, BBP-711, BBP-631 and BBP-454.

BBIO Intrinsic Value
30.56 USD
Undervaluation 23%
Intrinsic Value
Price

See Also

What is BridgeBio Pharma Inc's Gross Profit?
Gross Profit
215.4m USD

Based on the financial report for Sep 30, 2024, BridgeBio Pharma Inc's Gross Profit amounts to 215.4m USD.

What is BridgeBio Pharma Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
55%

Over the last year, the Gross Profit growth was 3 008%. The average annual Gross Profit growth rates for BridgeBio Pharma Inc have been 58% over the past three years , 55% over the past five years .

Back to Top